Neptune Technologies & Bioresources Inc - 12 Year Stock Price History | NEPT

Historical daily share price chart and data for Neptune Technologies & Bioresources Inc since 2007 adjusted for splits. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for Neptune Technologies & Bioresources Inc as of March 20, 2019 is 3.32.
Neptune Technologies & Bioresources Inc Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 3.4458 2.7600 3.7800 2.7000 3.3200 30.71%
2018 3.1887 2.3900 4.7200 2.3600 2.5400 7.63%
2017 1.0492 0.9701 2.3600 0.7199 2.3600 142.80%
2016 1.0622 1.0000 1.4500 0.8630 0.9720 -9.16%
2015 1.4288 1.8799 1.9800 0.9748 1.0700 -43.68%
2014 2.3187 2.9800 3.6100 1.4300 1.9000 -34.48%
2013 2.9860 1.9100 4.2200 1.7800 2.9000 44.28%
2012 3.5129 2.4899 4.9400 1.7100 2.0100 -31.16%
2011 2.9759 2.7900 4.4400 2.0380 2.9200 17.74%
2010 1.8374 2.0500 2.4800 1.0800 2.4800 20.39%
2009 1.5517 0.6001 2.5200 0.4800 2.0600 267.86%
2008 2.3447 4.5300 4.5900 0.2900 0.5600 -87.67%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.270B $0.022B
Neptune Wellness Solutions Inc. operates as a nutrition supplement company. It develops and produces cannabis products, marine oils, seed oils and pet supplements. Neptune Wellness Solutions Inc., formerly known as Neptune Technologies & Bioressources Inc., is headquartered in Laval, Canada.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $140.447B 27.76
Medtronic (MDT) Ireland $124.271B 18.17
Stryker (SYK) United States $73.087B 26.83
Boston Scientific (BSX) United States $52.902B 25.79
Baxter (BAX) United States $39.768B 25.44
Zimmer Biomet Holdings (ZBH) United States $25.701B 16.45
Smith & Nephew SNATS (SNN) United Kingdom $17.481B 0.00
Canopy Growth (CGC) Canada $15.431B 0.00
ResMed (RMD) United States $14.029B 26.60
Aurora Cannabis (ACB) Canada $10.082B 71.14
Bio-Rad Laboratories (BIO) United States $9.411B 53.70
Hill-Rom Holdings (HRC) United States $6.960B 21.53
Perrigo (PRGO) Ireland $6.690B 10.85
Insulet (PODD) United States $5.859B 1976.60
GW Pharmaceuticals (GWPH) United Kingdom $5.071B 0.00
ICU Medical (ICUI) United States $4.915B 30.60
Haemonetics (HAE) United States $4.429B 39.29
Hutchison China MediTech (HCM) China $3.856B 0.00
Agios Pharmaceuticals (AGIO) United States $3.806B 0.00
Neogen (NEOG) United States $3.332B 51.18
NuVasive (NUVA) United States $2.882B 25.14
Quidel (QDEL) United States $2.658B 23.98
Aphria (APHA) $2.606B 115.67
National Vision Holdings (EYE) United States $2.333B 45.89
HEXO (HEXO) $1.460B 0.00
Cardiovascular Systems (CSII) United States $1.372B 985.25
VAREX IMAGING (VREX) United States $1.306B 25.56
Phibro Animal Health (PAHC) United States $1.294B 18.60
AtriCure (ATRC) United States $1.108B 0.00
Lantheus Holdings (LNTH) United States $0.947B 25.58
MacroGenics (MGNX) United States $0.921B 0.00
Cerus (CERS) United States $0.868B 0.00
Omeros (OMER) United States $0.861B 0.00
PetIQ (PETQ) United States $0.815B 23.33
NanoString Technologies (NSTG) United States $0.755B 0.00
Evolus (EOLS) United States $0.725B 0.00
OraSure Technologies (OSUR) United States $0.713B 31.24
Meridian Bioscience (VIVO) United States $0.705B 21.00
Eagle Pharmaceuticals (EGRX) United States $0.680B 23.15
TG Therapeutics (TGTX) United States $0.653B 0.00
Surmodics (SRDX) United States $0.616B 89.55
LeMaitre Vascular (LMAT) United States $0.610B 29.03
Quanterix (QTRX) United States $0.550B 0.00
BioLife Solutions (BLFS) United States $0.376B 155.15
Insys Therapeutics (INSY) United States $0.358B 0.00
Rockwell Medical (RMTI) United States $0.357B 0.00
Vapotherm (VAPO) United States $0.335B 0.00
Utah Medical Products (UTMD) United States $0.313B 20.35
Owens & Minor (OMI) United States $0.283B 3.91
Bovie Medical (APYX) United States $0.266B 0.00
Cytosorbents (CTSO) United States $0.252B 0.00
Fonar (FONR) United States $0.143B 7.64
Surface Oncology (SURF) United States $0.142B 0.00
Zynex (ZYXI) United States $0.142B 15.17
Chimerix (CMRX) United States $0.103B 0.00
Chembio Diagnostics (CEMI) United States $0.101B 0.00
Female Health (VERU) United States $0.098B 0.00
United-Guardian (UG) United States $0.088B 18.33
Conatus Pharmaceuticals (CNAT) United States $0.087B 0.00
InfuSystems Holdings (INFU) United States $0.087B 0.00
CAS Medical Systems (CASM) United States $0.071B 0.00
Trinity Biotech (TRIB) Ireland $0.069B 20.64
Oramed Pharmaceuticals (ORMP) United States $0.058B 0.00
Neurotrope (NTRP) United States $0.056B 0.00
Valeritas Holdings (VLRX) United States $0.038B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
Senestech (SNES) United States $0.025B 0.00
Capricor Therapeutics (CAPR) United States $0.017B 0.00
Myomo (MYO) United States $0.016B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.015B 0.00
Akers Biosciences Inc (AKER) United States $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.014B 0.00
NeuroMetrix (NURO) United States $0.008B 15.00